Curia

#AAPSPharmSci360 Curia’s end-to-end CDMO capabilities and expertise can guide you through early development and clinical programs, supporting both small and large molecules, as well as formulation and drug product development. >>>> Schedule a meeting today, and let’s create a tailored program for your needs https://ow.ly/wSc450TqfgX >>>> Visit Curia at Booth 2703 at AAPS PharmSci 360, Oct. 20-23 in Salt Lake City, Utah #Curia #AAPSPHARMSCI360 #CDMO #SmallMolecules #Biologics #DrugProduct #sterilefillfinish #labtesting #DMPK

✨ OPCU Small Molecule Capacity Update Partner Spotlight: Curia is a CDMO with over 30 years of experience, an integrated network of 25 global sites and over 3,500 employees partnering with customers to make treatments broadly accessible to patients. Their small molecule offering spans discovery to commercial manufacturing and fill-finish services, integrating scientific, process, regulatory and analytical capabilities for API life cycle. Join us at the Small Molecule Capacity Update on October 23rd to find a CDMO fit for your project: https://lnkd.in/eJtNWsWX Event sponsored by Pharma Expanse

#WhatWeDoMatters Curia’s VP of API Manufacturing, Barbara Kucharczyk, recently had a rewarding moment educating her mom’s doctor about Curia’s role in producing a key prostate cancer drug he sources. At Curia, our efforts make a real difference in healthcare. --- Learn more about us: https://ow.ly/iPgn50TpyMJ #FromCuriosityToCure #CDMO #APIs #HPAPI #SmallMolecules #Biologics #drugmanufacturing

From Curiosity to Cure – Curia is your trusted ally. We are dedicated to partnering with you across modalities and services: Small Molecules, Generic APIs, and Biologics. >>> Schedule a meeting with one of our experts or stop by Hall 7 – Stand 7A18. https://ow.ly/Omqz50TaPfO Let’s build a partnership! #curia #cphimilan #curiositytocure #dedicatedallly # biologics #smallmolecules #genericapis #cytotoxiccompounds #lipids #drugdiscovery #drugdevelopment #manufacturing

Curia will be at #AAPSPharmSci360 in Salt Lake City, October 20 - 23. Visit our booth 2703 or schedule a meeting with our experts now >>> https://ow.ly/U54T50TqfaK Discover how our market-leading technologies and 30+ years of experience providing full-service formulation and manufacturing services can support your clinical and commercial programs, no matter how complex. --- >>> Not attending PharmSci360, but would like to speak with an expert? Please contact us at https://ow.ly/gAZ850TrGce #Curia #CDMO #DrugFormulation #FSF #ClinicalResearch #Manufacturing #Sterilefillfinish #analyticaltesting

#ADHDAwarenessMonth AWARENESS IS KEY to ending the stigma around Attention-Deficit/Hyperactivity Disorder, enabling people with ADHD to access the resources, information, and support they need to thrive. This month, we're helping to break down some of the myths surrounding ADHD. >>> MYTH: ADHD is just an excuse for laziness. FACT: ADHD is really a problem with the chemical dynamics of the brain and it’s not under voluntary control. --- MYTH: Everyone has a little ADHD FACT: Not everyone has the physical differences in the brain associated with ADHD. --- MYTH: ADHD Meds are addictive FACT: The therapeutic use of stimulant medications for ADHD actually helps prevent addiction. Additionally, there are some non-stimulant ADHD medicines such as Viloxazine available. --- Curia is proud to serve the HEALTHCARE COMMUNITY dedicated to IMPROVING THE LIVES of PEDIATRIC PATIENTS (ages 6 to 17) with ADHD. We offer Viloxazine HCI API for regulatory purposes. >>> Learn more about our APIs: https://ow.ly/ARlf50T5auP #CDMO #API #ADHD #AwarenessIsKey

#Biologics: At Curia, we’ve developed a comprehensive cell line engineering platform with customizable solutions to meet your project needs. Our cell lines are versatile tools for reporter assays, functional analysis of target proteins, antibody discovery, protein production, and drug screening. ---- Learn more about our cell engineering and production services: https://ow.ly/718Y50SJ62R #CDMO #DrugDiscovery #CellLineEngineering

✨ OPCU Fill/Finish Capacity Update Partner Spotlight: Curia is a CDMO with over 30 years of experience, an integrated network of 25 global sites and over 3,500 employees partnering with customers to make treatments broadly accessible to patients. Their biologics and small molecule offering spans discovery through commercialization, with integrated regulatory and analytical capabilities. Join us at the Fill/Finish Capacity Update on October 25th to find a CDMO fit for your project: https://lnkd.in/dZYMucWS Event sponsored by Stevanato Group

At Curia, we recognize that #diversity fuels #innovation and #success. This #HispanicHeritageMonth we are proud to support and celebrate the rich culture and significant contributions and accomplishments of our Hispanic and Latino American employees, partners and communities. --- Discover more about Curia’s cultural awareness and commitment to corporate responsibility: https://ow.ly/phpt50Tuf0X #TheCuriaWay

At Curia, we are large enough to take on the complex discovery, drug development and manufacturing challenges from around the world. Yet, we are small enough to build a personalized, one-to-one approach. >>> Schedule a meeting with us at CPHI today: https://ow.ly/EI0f50TaOQv >>> Meet with us Hall 7, Stand 7A18 so we can customize a solution for YOU! #curia #cphimilan #curiositytocure #biologics #smallmolecules #genericapis #cytotoxiccompounds #lipids #drugdiscovery #drugdevelopment #manufacturing